http://www.guardian.co.uk/uslatest/story/0,1282,-2892001,00.htmlPHILADELPHIA (AP) - The maker of the
discontinued Lymerix Lyme disease vaccine has
agreed to settle class-action lawsuits alleging that
it could cause an arthritic condition in some
people, but those who received the vaccine will
get nothing from the settlement.
SmithKline Beecham, now GlaxoSmithKline, took
Lymerix off the market in February 2002, which
the plaintiffs' attorneys said accomplished the
main goal of the lawsuits.
The only money to change hands will be fees of
$926,250 and costs of $137,997 that
GlaxoSmithKline agreed to pay the lawyers, an
amount that concerned Chester County Judge
Jacqueline C. Cody.
A half dozen class-action lawsuits filed in New
York, New Jersey and Pennsylvania were
consolidated in her court, and Cody said 34
attorneys and paralegals submitted bills for work.